A trilayer biodegradable food packaging film combining zein, layered double hydroxides (LDHs), and chitosan via plasma-assisted layer-by-layer assembly. Designed to significantly reduce oxygen and water vapor permeability while improving mechanical strength and thermal stability for sustainable food packaging applications.
This research presents an advanced approach to biodegradable food packaging by developing a trilayer film that integrates layered double hydroxides (LDHs) with cold plasma-assisted layer-by-layer assembly. The technology targets a critical challenge in sustainable packaging: achieving barrier performance comparable to conventional plastics while maintaining biodegradability. By combining zein protein, LDH nanomaterials, and chitosan in a structured trilayer configuration, the film aims to significantly reduce oxygen and water vapor permeability, extend shelf life of packaged foods, and reduce reliance on petroleum-based packaging materials.
The solution addresses growing market demand for high-performance sustainable packaging driven by regulatory pressures and consumer preferences for environmentally responsible products.
This technology is currently at the laboratory research and proof-of-concept stage. The proposed validation procedures include systematic barrier property testing, mechanical strength evaluation, and thermal stability analysis using established ASTM and standard analytical methods. Further development would involve scaling the plasma-assisted assembly process, optimizing LDH loading concentrations, and conducting shelf-life studies with real food products to validate commercial viability. The research team is positioned to advance toward pilot-scale trials and industry-relevant testing with appropriate collaborative partnerships.
UBC is a comprehensive public research university with major campuses in Vancouver and the Okanagan, among Canada’s largest and most internationally connected. Industry engages through a co-op talent pipeline and collaborative research spaces that include co-located clinical settings and on‑campus testbeds. A dedicated technology transfer office brokers partnerships, manages IP and licensing, and is complemented by an active venture accelerator and incubator network. Research is supported by competitive funding from Canada’s Tri‑Council agencies (NSERC, CIHR, SSHRC) and infrastructure investments from the Canada Foundation for Innovation, alongside provincial and industry sponsorship.